Concentra Group Holdings Parent, Inc.

CON trades at an 18.2 P/E while sitting at an RSI of 54.2—neither stretched nor deeply discounted—suggesting measured momentum in a healthcare services name with $3.2B market cap. The 3.1% short interest is negligible, indicating minimal squeeze risk and broad acceptance of the valuation. The stock's distance from its 52-week high hints at room for appreciation if the specialty outpatient facility operator can demonstrate earnings acceleration, though the mid-range valuation multple doesn't scream bargain relative to sector peers. Without explosive growth catalysts, this appears positioned as a steady holding rather than a high-conviction trade setup.